- Home
- ACCL vs ABVC Comparison
ACCL vs ABVC Comparison
Compare ACCL & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACCL
- ABVC
- Stock Information
- Founded
- ACCL 2009
- ABVC 2015
- Country
- ACCL Hong Kong
- ABVC United States
- Employees
- ACCL N/A
- ABVC N/A
- Industry
- ACCL Professional Services
- ABVC Biotechnology: Pharmaceutical Preparations
- Sector
- ACCL Consumer Discretionary
- ABVC Health Care
- Exchange
- ACCL Nasdaq
- ABVC Nasdaq
- Market Cap
- ACCL 57.8M
- ABVC 68.7M
- IPO Year
- ACCL 2025
- ABVC N/A
- Fundamental
- Price
- ACCL $3.94
- ABVC $2.72
- Analyst Decision
- ACCL
- ABVC
- Analyst Count
- ACCL 0
- ABVC 0
- Target Price
- ACCL N/A
- ABVC N/A
- AVG Volume (30 Days)
- ACCL 113.8K
- ABVC 61.3K
- Earning Date
- ACCL 12-05-2025
- ABVC 11-03-2025
- Dividend Yield
- ACCL N/A
- ABVC N/A
- EPS Growth
- ACCL 2.91
- ABVC N/A
- EPS
- ACCL 0.08
- ABVC N/A
- Revenue
- ACCL $4,888,824.00
- ABVC $797,916.00
- Revenue This Year
- ACCL N/A
- ABVC $735.18
- Revenue Next Year
- ACCL N/A
- ABVC N/A
- P/E Ratio
- ACCL $52.36
- ABVC N/A
- Revenue Growth
- ACCL 11.91
- ABVC 56.52
- 52 Week Low
- ACCL $2.10
- ABVC $0.40
- 52 Week High
- ACCL $5.00
- ABVC $5.48
- Technical
- Relative Strength Index (RSI)
- ACCL N/A
- ABVC 41.56
- Support Level
- ACCL N/A
- ABVC $2.77
- Resistance Level
- ACCL N/A
- ABVC $3.06
- Average True Range (ATR)
- ACCL 0.00
- ABVC 0.18
- MACD
- ACCL 0.00
- ABVC -0.02
- Stochastic Oscillator
- ACCL 0.00
- ABVC 12.79
About ACCL Acco Group Holdings Limited Ordinary Shares
Acco Group Holdings Ltd is a holding company. Through its Operating Subsidiaries, it is a multi-disciplinary, IT-driven corporate service provider with a presence in Hong Kong and Singapore. Under the Accolade brand, it specializes in offering corporate secretarial services and accounting services in Hong Kong, as well as intellectual properties (IP) registration services in Singapore. Leveraging developed IT solutions, It provides comprehensive, reliable and professional support to its clients, enabling them to focus on their core business activities while it manages and handles their corporate compliance needs. Its clientele ranges from individual clients, small and medium-sized enterprises to multinational corporations, reflecting its ability to cater to diverse business needs.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.